research use only
Cat.No.S2526
| Related Targets | Dehydrogenase HSP Transferase PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism Drug Metabolite |
|---|---|
| Other P450 (e.g. CYP17) Inhibitors | Apigenin Baicalein Avasimibe Naringenin Diosmetin Sodium Danshensu Naringin Benzbromarone Orteronel Danshensu |
|
In vitro |
DMSO
: 48 mg/mL
(199.82 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 240.21 | Formula | C14H8O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 72-48-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Anthraquinonic | Smiles | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O | ||
| Targets/IC50/Ki |
AhR
CYP1B1
2.7 μM
CYP1A1
6.2 μM
CYP1A2
10.0 μM
|
|---|---|
| In vitro |
Alizarin weakly inhibits CYP2A6 and CYP2E1. This compound shows competitive inhibition against CYP1B1 with Ki of 0.5 μM. It reduces the mutagenicity of MeIQx, which induced by each CYP1A2 or CYP1B1, while does not effectively reduce the mutation induced by B[a]P. This chemical exhibits antioxidants against iodophenol-derived phenoxyl radicals, superoxide anion radicals and lipid peroxidation in rat liver microsomes.
|
| In vivo |
Alizarin also reduces the hepatic content of thiobarbituric acid-reactive substances and the serum level of alanine aminotransferase in poisoned animals.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.